InvestWiser

Neola Medical AB

NEOLANasdaq StockholmHealthcareMarket value 56 m SEK
0.51SEK 0.0%
last day · Price as of 20 November 2026

The answer first

Does Neola Medical beat the market?

No, Neola Medical has not beaten the market over the last year.

Neola Medical−64.2%Stockholm (OMXSGI)+14.8%
  • The ranking · Quality, value and trend combined

    Better than 36% of Nordic stocks

    • Quality86
    • Value25
    • Trend23

    No. 90 of 195 in healthcare

Max for seven days

Follow Neola Medical with Aurora

Aurora lets you know at the next report. No card.

Both with dividends. Figures as of 20 November 2026. General analysis, not personal advice.

Follow your thesis

Follow your thesis on Neola Medical

From today, at a price of 0.51 SEK. Write why you follow Neola Medical, and choose what Aurora should tell you about.

What should Aurora follow?

Free, no card. The mission is ready when your account is.

Aurora tells you that something happened. What you do is your choice.

Ask Aurora about Neola Medical

Your first answer is free, no account needed.

Do you own Neola Medical, or are you thinking about it?

See it next to the rest of your portfolio, or build your first one with Neola Medical and a few more. Free, no card.

Past year against the exchange and Super Stock
Neola Medical−64.2%Stockholm (OMXSGI)+14.8%Super Stock+45.4%
19 November 202520 November 2026
All start at 0 % a year ago, with dividends. Super Stock is our model portfolio: the 20 highest-ranked Nordic stocks on quality, value and trend.

In short

  • Neola Medical has fallen 64.2% over the past year, including dividends.
  • Overall, Neola Medical ranks better than 36% of Nordic stocks on quality, value and trend.
  • The largest fall over the past three years was 85.8%. The price is 91.9% below its peak now.

What do analysts think of Neola Medical?

Quality, value and trend

Quality is about the company, value about the price you pay, and trend about the share price. Each pillar shows the numbers it is built on.

36

Quality, value and trend together. Better than 36% of Nordic stocks.

No. 90 of 195 in healthcare

Quality86
The company · Fundamentals: the accounts

High A solid company: it earns well on its money and has healthy finances.

No. 41 of 196 in healthcareTypical in healthcare: 64Typical in the Nordics: 50

  • Debt to equityBorrowings divided by equity–
  • Asset turnoverSales divided by everything the company owns0.00
  • Return on equityProfit divided by equity−13.0%
  • Cash conversionOperating cash flow divided by profit–

The ranking is built on equity ratio, ROA and how steadily profit grows.

Value25
The price · Valuation: the multiples

Low High price: buyers pay a lot today, often because they expect growth.

No. 82 of 197 in healthcareTypical in healthcare: 20Typical in the Nordics: 50

  • P/BPrice divided by equity0.4
  • P/SPrice divided by sales–
  • P/EPrice divided by earningsnegative earnings
  • P/CFPrice divided by operating cash flownegative earnings

The ranking is built on P/E, P/B and P/S.

Trend23
The share price · Technical: the price trend

Low Headwind in the share price: it has done worse than most over the last year.

No. 121 of 198 in healthcareTypical in healthcare: 33Typical in the Nordics: 50

  • 3 months+2.2%
  • 6 months−52.0%
  • 9 months−42.4%
  • 12 months−64.2%

The ranking is built on 3, 6 and 12–1 months.

Return and risk

1 month
−3.8%
3 years, per year
−27.3%
5 years, per year
−30.1%
Year to date
−52.4%
Largest fall, 3 years
−85.8%
From a peak to the bottom
From the peak now
−91.9%
How far the price is from the peak
Volatility, 1 year
120.8%
How much the price swings over a year
Beta, 1 year
−0.27
How much the price moves when the market moves

Return with dividends reinvested.

The funds that own Neola Medical

2 funds we follow own Neola Medical. The share is how much of the fund the stock makes up.

  • Sweden2

From the funds' latest known holdings.

About Neola Medical

Neola Medical AB is a company in healthcare, listed on Nasdaq Stockholm. By market value, Neola Medical is number 112 of 137 companies in healthcare on Nasdaq Stockholm. Neola Medical has not paid a dividend in the past twelve months. Of the three measures in the ranking, Neola Medical is strongest on quality, better than 86% of Nordic stocks. The share trades in SEK. It has around 9 employees.

Neola Medical AB (publ), together with its subsidiary, Neola Medical, Inc., develops medical technology devices for non-invasive continuous monitoring of the lungs of preterm born infants in Sweden. It offers NEOLA, a neonatal intensive care medical device that enables continuous lung monitoring and real-time alerts of life-threatening complications using technology that measures lung volume changes and oxygen gas concentration. The company was formerly known as GPX Medical AB and changed its name to Neola Medical AB (publ) in June 2022. Neola Medical AB (publ) was incorporated in 2016 and is headquartered in Lund, Sweden.

See the full analysis of Neola Medical.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

Free forever · No card

Other healthcare stocks on Nasdaq Stockholm

Explore the stock market